IA
ORIC icon

IFP Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

IFP Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
1,028
+731
+246% +$6.63K ﹤0.01% 3328
2026
Q1 		$3.76K Hold
297
– – ﹤0.01% 3691
2025
Q4 		$2.43K Hold
297
– – ﹤0.01% 3767
2025
Q3 		$3.56K Hold
297
– – ﹤0.01% 3439
2025
Q2 		$3.02K Buy
297
+285
+2,375% +$1.91K ﹤0.01% 3698
2025
Q1 		$67 Hold
12
– – ﹤0.01% 3963
2024
Q4 		$97 Buy
+12
New +$110 ﹤0.01% 4045

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IFP Advisors's ORIC Position: Q2 2026 in Review

IFP Advisors increased its Oric Pharmaceuticals (ORIC) stake by 246% in Q2 2026, buying an estimated $6.63K and bringing the position to 1,028 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3328.

IFP Advisors first reported a position in ORIC in Q4 2024 and has held it in 7 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • IFP Advisors held 1,028 shares of Oric Pharmaceuticals worth $11.1K as of Q2 2026.
  • IFP Advisors bought 731 Oric Pharmaceuticals shares in Q2 2026, an estimated $6.63K.
  • Oric Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3328 holding.
  • IFP Advisors first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.